key: cord-1029423-nek2ygc3 authors: Saeed, Sahrai; Mancia, Giuseppe title: Arterial stiffness and COVID‐19: A bidirectional cause‐effect relationship date: 2021-05-05 journal: J Clin Hypertens (Greenwich) DOI: 10.1111/jch.14259 sha: 2630cfc846ae8f87d2cabfd148cbe9aa139e3cf6 doc_id: 1029423 cord_uid: nek2ygc3 nan Coronavirus disease 2019 (COVID-19) primarily affects the lungs but the clinical manifestations vary markedly among the patients involved. In more severe cases, COVID-19 can lead to acute respiratory distress syndrome (ARDS), multi-organ failure including cardiac injury and toxic shock syndrome with need for intensive care and a ventilator support, 1 while at the opposite extreme the signs and symptoms can be those of a mild flu and in many patients the infection is asymptomatic. Since the outbreak of the infection in China, a large number of studies have consistently reported on the cardiovascular (CV) complications of COVID-19 which include acute cardiac injury, cardiac arrhythmias, and diffuse endothelial damage leading to microvascular thrombosis and thromboembolic events. Evidence has also consistently suggested that cardiac, vascular, renal, and cerebral damages associated with CV risk factors such as hypertension, diabetes, dyslipidemias, and obesity markedly increase the risk of COVID-19 progression to its most severe and lethal forms, presumably because the pre-existing structural and functional alterations of the organs affected by long-lasting blood pressure elevation and metabolic alterations weaken their resistance to the virus. Resistance to the virus may be further reduced by the pathogenetic nature of some of these organ alterations, that is, by the fact the most common cause of risk factor-dependent complications, atherosclerosis, is likely to be codetermined by an inflammatory process that may adversely interact with that of the coronavirus. 1 As far as obesity, a major component of the metabolic syndrome, is concerned, its relationship with the COVID-19 severity may be due to its association with chronic low grade inflammation, higher leptin and lower adiponectin levels, immune response dysregulation, and abnormal pro-inflammatory cytokine production. 2 The association between increased arterial stiffness and the se- Finally, Rodilla et al showed that a pulse pressure of ≥60 mmHg at admission, as a surrogate marker of arterial stiffness, was associated with higher risk of all-cause mortality (adjusted odds ratio 1.27, P =.0001) in hospitalized COVID-19 patients. 11 In addition, in an individual case study involving a 55-year-old man with obesity and no previously known hypertension, we recently showed that several months after recovery from COVID-19, the patient had sustained tachycardia and elevated blood pressure at rest. We speculated that the activation of renin-angiotensin and sympathetic systems, inflammation-induced systemic cytokine, volume overload and associated hyperreninemia, inflammation, and vasculitis may have contributed to an exaggerated cardiovascular response and sustained tachycardia at rest. 12 However, whether this persistently elevated heart rate and blood pressure was a consequence of COVID-19induced increased arterial stiffness, or an untreated persistent abnormal CV response is the primary responsible factor for an incident increased arterial stiffness, is a matter for well-designed prospective studies on COVID-19 survivors to clarify. Endothelial dysfunction is believed to be a key element in the pathogenesis of COVID-19-related organ damage. 13 Whether COVID-19 patients are predisposed to early atherosclerosis is not yet fully understood. However, it is reasonable to be- Statin lower CV risk factors through their lipid-lowering and pleiotropic or anti-inflammatory effects. 25 It has been also postulated that statin may act as a SARS-CoV-2 main protease inhibitor. 26 We should acknowledge that this opinion piece is prepared from a clinical point of view and hence hypothesis generating. The molecular mechanism is not discussed, although these are still poorly un- None. No conflict of interest. Coronavirus disease 2019 and cardiovascular complications: focused clinical review Online ahead of print COVID-19 and the role of chronic inflammation in patients with obesity Association for research into arterial structure, physiology (ARTERY) society, the european society of hypertension (ESH) working group on vascular structure and function, and the european network for noninvasive investigation of large arteries. vascular consequences of inflammation: a position statement from the ESH working group on vascular structure and function and the ARTERY society Inflammation and aortic stiffness: an individual participant data meta-analysis in patients with inflammatory bowel disease COVID-19 and ethnicity: A novel pathophysiological role for inflammation Arterial stiffness and the development of hypertension: the ARIC study Aortic stiffness, blood pressure progression, and incident hypertension Arterial stiffness and hypertension: chicken or egg? Arterial stiffness in acute COVID-19 and potential associations with clinical outcome Vascular alterations among young adults with SARS-CoV-2 SEMI-COVID-19 network. impact of arterial stiffness on all-cause mortality in patients hospitalized with COVID-19 in Spain Characteristics of the 24-hour ambulatory blood pressure monitoring in a COVID-19 survivor Endothelial dysfunction in COVID-19: Current findings and therapeutic implications The Enigma of Endothelium in COVID-19 The cytokine storm of COVID-19: a spotlight on prevention and protection Hypertension, thrombosis, kidney failure, and diabetes: Is COVID-19 an endothelial disease? a comprehensive evaluation of clinical and basic evidence Vigilance on new-onset atherosclerosis following SARS-CoV-2 infection Endothelial cell infection and endotheliitis in COVID-19 COVID-19-related stroke Thrombosis as an intravascular effector of innate immunity Potential mechanisms of cerebrovascular diseases in COVID-19 patients SARS-CoV-2 mediated endothelial dysfunction: the potential role of chronic oxidative stress Atherosclerosis as pathogenetic substrate for Sars-Cov2 cytokine storm Adverse cardiovascular magnetic resonance phenotypes are associated with greater likelihood of incident coronavirus disease 2019: findings from the UK Biobank Effect of statins on tolllike receptors: A new insight to pleiotropic effects Statins and the COVID-19 main protease: In silico evidence on direct interaction Mount sinai COVID informatics center. prevalence and impact of myocardial injury in patients hospitalized with COVID-19 infection The efficacy of colchicine in the management of coronavirus disease 2019: Aprotocol for systematic review and meta-analysis